Publications (controller)
Implantable diagnostic device for cancer monitoring.
Biosens Bioelectron. 2009;24(11):3252-7 - PMID: 19442510 - PMCID: PMC2738970
The evolving radiology landscape: the importance of effective leadership.
Eur J Radiol. 2009;19(10):2321-5 - PMID: 19471944
Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.
Clin Imag. 2009;33(4):301-5 - PMID: 19559353
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.
Nat Med. 2008;14(12)::1351-1356 - PMID: 19029981 - PMCID: PMC2683415
BRAF activation initiates but does not maintain invasive prostate adenocarcinoma.
PLoS ONE. 2008;3(12):e3949 - PMID: 19079609 - PMCID: PMC2597248
Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model.
Pancreas. 2008;37(4):440-4 - PMID: 18953259
Pilot Study Evaluating Use of Lymphotrophic Nanoparticle-Enhanced Magnetic Resonance Imaging for Assessing Lymph Nodes in Renal Cell Cancer.
Urology. 2008;71(4):708-12 - PMID: 18295316
The radiologist's conundrum: benefits and costs of increasing CT capacity and utilization.
Eur J Radiol. 2008;:ePub - PMID: 18766347
Radiology report turnaround: expectations and solutions.
Eur J Radiol. 2008;18(7):1326-8 - PMID: 18327594
Utility of a New Bolus-Injectable Nanoparticle for Clinical Cancer Staging
Neoplasia. 2007;(9)12:1160-1165 - PMID: 18084623 - PMCID: PMC2134912
10


